International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 1048-1051 doi: 10.5281/zenodo.16942161
Research Article
A Clinical Study of Acceptability & Safety of PPIUCD and Interval IUCD In RMC , Ajmer (Rajsthan)
 ,
 ,
 ,
 ,
Received
July 7, 2025
Accepted
Aug. 16, 2025
Published
Aug. 25, 2025
Abstract

Background -A clinical prospective study in terms of acceptability , safety and complications of PPIUCD and Interval IUCD.

IUCD is most commonly used long acting reversible method of  contraceptive .

Method – Total 1500 women were counselled in antenatal , early labour and post natal period  .   women who accepted PPIUCD , were insertd PPIUCD after excluding chorioamnionitis ,PROM > 18 hrs , PPH , puerperal sepsis .Total 150 women counselled for Interval IUCD who came to family planning clinic  or routine OPD out of which 30 women accepted interval IUCD . All women followed upto 6 months to see safety and complications .

Results – Acceptability was slightly higher for PPIUCD ( 26.60 %) as compared with Interval IUCD (20%) . Safety of IUCD was almost similar in both groups with minor side effects  ( 52 % v/s 73.30 %) .

Conclusion _ IUCD is a safe , feasible and reversible method of contraception.

 

Keywords
INTRODUCTION

India is the most populated country in world with 1.45 billion people .Family planning with adequate spacing between the pregnancies  can prevent about 32% of maternal death & 10 % child mortality .Pregnancies with less than recommended spacing  can lead to obstetric complication like anaemia , spontaneous abortion , preterm labour , post partum haemorrhage & maternal mortality also. Fetal complication like SGA & fetal deaths are more till  2 years after delivery ,because a women will not be ready physically to conceive & delivery. Hence practice of contraception is essential for women health . There is different types of contraception , but not all types appropriate for all situations . IUCDs are the top tier of contraceptives as they are  safe ,  long acting , cost effective  with no major side effects .

 

AIMS & OBJECTIVES

A clinical study of PPIUCD & Interval IUCD in terms of acceptability , safety & complications .  

 

MATERIAL & METHODS

This was  a hospital based prospective study conducted in    patients who delivered in RMC Ajmer  or  who came to family planning clinic or routine OPD & searching  for long acting reversible method of contraception .

 Study group :1500 women  in PPIUCD group & 150 in Interval IUCD group .

Inclusion criteria  - All women who  delivered at RMC Ajmer or who came for  long acting reversible method of contraception .

Exclusion criteria   ;  Women who did not provide informed consent , H/O  APH , PROM > 18 hrs , PPH ,  coagulation disorder , allergy to copper , genital tract infection or active STI  , Chorioamnionitis , fever during labour and delivery , anomalous uterus , known uterine fibroid , HIV positive mothers taking ART .

 

All women who accepted this method  of contraception , IUCDs were placed with proper technique under aseptic conditions  .These  cases are are followed up at 15th day , 6th week  6th  month  .

 

RESULTS 

Total acceptability rate of PPIUCD was 26.60% & Interval IUCD was 20 % in  our study. Majority of cases  who accepted IUCD  belonges to 18- 30 years for both groups.( Table 1 & 2 ) .

 

Table No-  1 Distribution of patients according to Parameters .

Parameter

PPIUCD

Group

Interval IUCD

Group

Awareness of IUCD

58%

53.33%

 Acceptability

26.60%

20%

Minor side effects

52%

73.30%

 

This  study showed that acceptability  of IUCD was slightly higher in PPIUCD Group. Awareness  was also higher in PPIUCD group ( 58 % ) as compared to interval IUCD (53.33 %) . Minor side effects ( heavy menstrual bleeding , white discharge , pain etc .) was more in interval IUCD group ( 52 % v/s 73. 30 %) .

 

Table No- 2 Distribution of patients according to Age.

Age Distribution (in

years)

PPIUCD Group

Interval IUCD Group

No. of Patients

Percentage

No. of Patients

Percentage

18-30

337

84.25

16

53.33

31-40

57

14.25

12

40.00

>40

6

1.5

2

6.67

Total

400

100

30

100.00

Mean±SD

26.007±5.02

30.03±5.37

P-Value

<0.0001

  

The maximum  age of users  of IUCD  was 18 -30  years in both groups . The age distribution showed that in the 18–30 years category, PPIUCD Group had 337 patients (84.25%) while Interval IUCD Group had 16 patients (53.33%). In the 31–40 years group, there were 57 patients (14.25%) in PPIUCD Group and 12 patients (40.00%) in Interval IUCD Group. Patients aged over 40 years accounted for 6 (1.5%) in PPIUCD Group and 2 (6.67%) in Interval IUCD Group. The total number of patients was 400 in PPIUCD Group and 30 in Interval IUCD Group. The mean age in PPIUCD Group was 26.007 ± 5.02 years, whereas in Interval IUCD Group it was 30.03 ± 5.37 years. This difference in mean age between the two groups was statistically significant, with a p-value of <0.0001.

 

Table No- 3 Distribution of patients according to Parity -

Parity

PPIUCD Group

Interval IUCD Group

P-Value

No. of Patients

Percentage

No. of Patients

Percentage

Primipara

185

46.25

4

13.33

0.0004

Multipara

215

53.75

26

86.67

Total

400

100

30

100.00

 

 

Most of women who accepted IUCD were multipara ( 53. 75 % v/s 86.67 % ) in both groups  .( Table 3 ) .

 

Table No- 4  Distribution of patients according to cause of Acceptance.

Cause of Acceptance

PPIUCD Group

Interval IUCD Group

P-

Value

No. of

Patients

Percentage

No. of

Patients

Percentage

Fewer Clinical

Visits

16

4

4

13.33

0.02

Long term

108

27

12

40.00

Reversible

256

64

12

40.00

Safe

20

5

2

6.67

Total

400

100

30

100.00

 

Regarding the cause of acceptability of  IUCD most common cause in PPIUCD was reversibility ( 64 %)  and for Interval IUCD were long term use and reversibility ( 40 % each ( Table 4)

 

Table  5 -Distribution of patients according to complications -

Complication

PPIUCD Group

Interval IUCD Group

P-Value

No. of Patients

Percentage

No. of Patients

Percentage

Pregnancy

1

0.25

0

0.00

0.78

Expulsion

14

3.5

3

10.00

0.07

Missing of thread

15

3.75

6

20.00

0.0001

HMB

35

8.75

5

16.67

0.15

Abdominal cramps

91

22.75

8

26.67

0.62

White Discharge

52

13

0

0.00

0.03

No Complications

53

13.25

0

0.00

0.03

 

Regarding complications, pregnancy occurred in 1 patient (0.25%) in PPIUCD Group and none in Interval IUCD Group (p = 0.78). Expulsion was reported in 14 patients (3.5%) in PPIUCD Group and 3 patients (10%) in Interval IUCD Group (p = 0.07). Missing strings were significantly more common in Interval IUCD Group, with 6 patients (20%) affected compared to 15 patients (3.75%) in PPIUCD Group (p = 0.0001). Heavy menstrual bleeding (HMB) occurred in 35 patients (8.75%) in PPIUCD Group and 5 patients (16.67%) in Interval IUCD Group (p = 0.15). Abdominal cramps was reported by 91 patients (22.75%) in PPIUCD Group and 8 patients (26.67%) in Interval IUCD Group (p = 0.62). White discharge was present in 5.

DISCUSSION

A 30% reduction in maternal deaths and 10% reduction in child deaths was observed in females who used family planning methods with the intention to create interval of at least 3 years apart between births . Short intervals among births are associated with greater mother and child morbidity as well as mortality. Despite of these facts, only 26% of postpartum women are using contraceptive methods and more than 60% of births follow a track with an interval of less than 3 years. The intrauterine contraceptive devices (IUCD) are one of the commonest methods for contraception. CuT 380A is a little coil, usually in the form of T- shape letter that is placed into a womb to prevent pregnancy . The IUCD is a highly effective, long acting, reversible, cost effective and easily accessible family planning method that is safe for used by most postpartum women including those who are breast feeding or any time during reproductive age. Awareness and removing the stigma about the use of IUCD especially in the postpartum period holds importance since it may help in reducing morbidity and mortality of mother and fetes, which is due to high India that is presently having population crisis.

 

This study aims to determine proportion of women accepting  PPIUCD & Inerval IUCD  Insertion.

 

CONCLUSION

Our study showed that Intra uterine contraceptive devise is a safe , effective and long acting reversible method contraceptive.Women are highly motivated during the postpartum period and receptive to family planning advise & no additional visits are required for contraception .

 

ADDITIONAL INFORMATIO

 Auther Contributions

All authers have reviewed the final version to be published and agreed to be accountable for all aspects of the work .

Concept and design – Navita kumawat , Renu meena

Acquistion , analysis or interpretation of data – Navita k , Sandhya choudhary , Suchitra Narayan

Drafting  of manuscript – Navita Kumawat , Arjun Singh

REFERENCES

1. EL Beltagy NS Darwish EA , Kasem MS , Hefila NM . Comparison between CuT380A and Multiload 375 in early postpartum insertion – East fertility society J.2010 ;16:143-8. 2. Mohan H, Rmappa R , Sandesh M ,Akash BK. PPIUCD versus Interval IUCD insertion ;a comparative study in a referral hospital of Karnataka , India . Int J Reprod contracept Obstet Gynecol 2015 ;4:1730 -2. 3. Priya S, Tuteja A , Mittal P , Diwan R ,Suri j ,Kumar A .Exploring reasons behind low acceptance for PPIUCD in postnatal womwn.New Indian J surg.2011;2;246. 4. Saroj k,Neha G. Acceptibility for the use of PPIUCD ,znana hospital Jaipur .IntvJ Sci Res. 2016 ;5 401-9 . 5. .World Health Organization. Selected practice recommendations for contraceptive use.Geneva: WHO,2004b. 6. Eroglu K, Akkuzu G, Vural G, Dilbaz B, Akin A, Taskin L, et al. Comparison of efficacy and complications of IUD insertion in immediate postpartum/ early postpartum period with interval period: 1 year follow up. Contraception. 2006;74(5):376-81 7. Alvior GT, Jr Pregnancy outcome with removal of intrauterine device. Obstet Gynecol. 1973;41:894–896. 8. Kulier R, O’Brien PA, Helmerhorst FM, UsherPatel M, D’Arcangues C. Co pper containing, framed intra-uterine devices for contraception. Cochrane Database Syst Rev 2007(4):CD005347. 9. Mohamed AI, Abd Elati IH, Ramadan EN. Assessment Effect of Post Puerperal and Immediate Post Placental Intrauterine Contraceptive Devices Insertion after Cesarean Delivery on Women's Health. IOSR Journal of Nursing and Health Science.2015;4(3):1-7.doi:10.9790/1959-04310107. 10. Kanhere AV, Pateriya P, Jain M. Acceptability and feasibility of immediate postpartum IUCD insertion in a tertiary care centre in Central India. Int J Reprod Contracept ObstetGynecol .2015; 4:179-84. doi: 10.5450- 1770.ijrcog20150232. 11. Kittur S, Kabadi YM. Enhancing contraceptive usage by post-placental intrauterine contraceptive devices (PPIUCD) insertion with evaluation of safety, efficacy, and expulsion. Int J Reprod Contracept Obstet Gynecol. 2012 Dec; 1(1):26-32.doi:10.5455/2320-1770.ijrcog001112 12. Singal S, Bharti R, Dewan R, Divya ,DabralA, Batra A et al. Clinical Outcome of Postplacental Copper T 380A Insertion in Women Delivering by Caesarean Section. Journal of clinical and diagnostic research.2014 Sep; 8(9):OCO1-OC04. Doi:10.7860/jcdr/ 2014/10274. 4786. 13. Jain N, Akhtar N. A Study to Compare the Efficacy, Safety &Outcome of Immediate Postpartum Intrauterine Contraceptive Device (PPIUCD) With That of Delayed Insertion. International Journal of Science and Research (IJSR).2015 Feb;4(2):1388-1391. 14. Katheit G, Agarwal J. Evaluation of post-placental intrauterine device (PPIUCD) in terms of awareness, acceptance, and expulsion in a tertiary care centre. Int J Reprod Contracept Obstet Gynecol. 2013 Dec; 2(4): 539- 543.doi:10.5455/2320-1770.ijrcog20131210 15. Sultana R, Jameel A, Amjad A. Immediate Postpartum Insertion of Intrauterine Device: An Ideal Method. JSOGP.2015;5(1):34-39.

Recommended Articles
Research Article
The Cumulative Burden: A Case of Alcoholic Liver Disease, HIV, And Laryngeal Carcinoma in Chronic Substance Abuse
...
Published: 24/08/2025
Case Report
Nature’s Error…In Mirror He or She…Swyers Syndrome - A Rare Case
...
Published: 25/08/2025
Research Article
Knowledge and Practice of Breastfeeding and Complementary Feeding Among Mothers of Under One Year Age Children
Published: 25/08/2025
Research Article
Clinico-Epidemiological Characteristics and Dermoscopic Patterns of Vitiligo in Adults: A Cross-Sectional Study
Published: 22/08/2025
Loading Image...
Volume-6, Issue-4
Citations
7 Views
13 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved